cyclophilin inhibitors (SCYNEXIS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecyclophilin inhibitors (SCYNEXIS)
Drug Alias Namecyclophilin inhibitors (SCYNEXIS)SCY-644
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptidylprolyl isomerase inhibitors
TargetsPeptidylprolyl isomerase
Therapy Area/IndicationsInflammationHepatitis CHepatitis B +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesScynexis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScynexis Inc
Active IndicationsN/A
Inactive IndicationsInflammationHepatitis CHepatitis B +[4] 

Other Information

ATC CodeN/A
Related LinksN/A